Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Moodys
Cipla
Citi
AstraZeneca
Teva
US Army
Colorcon
Cantor Fitzgerald

Generated: February 25, 2018

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for clindamycin phosphate and what is the scope of clindamycin phosphate freedom to operate?

Clindamycin phosphate
is the generic ingredient in seventeen branded drugs marketed by Perrigo Uk Finco, Mylan Pharms Inc, Pharmacia And Upjohn, Fougera Pharms, Perrigo Pharma Intl, Precision Dermat, Abraxis Pharm, Alvogen Inc, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Igi Labs Inc, Loch, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Akorn Inc, Baxter Hlthcare Corp, Sandoz Inc, Abbvie, Baxter Hlthcare, Paddock Llc, Boca Pharma Llc, Fougera Pharms Inc, G And W Labs Inc, Glasshouse Pharms, Novast Labs Ltd, Perrigo New York, Taro Pharm Inds, Teligent Pharma Inc, Vintage Pharms, Wockhardt, Akorn, Perrigo Co, Actavis Mid Atlantic, Aqua Pharms Llc, and Medicis, and is included in seventy NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clindamycin phosphate has one hundred and thirty-two patent family members in thirty-eight countries.

There are fifty-four drug master file entries for clindamycin phosphate. Thirty-four suppliers are listed for this compound.
Summary for CLINDAMYCIN PHOSPHATE
Pharmacology for CLINDAMYCIN PHOSPHATE

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 065254-001 Feb 14, 2006 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate GEL;TOPICAL 064160-001 Jan 28, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Perrigo Pharma Intl CLINDESSE clindamycin phosphate CREAM;VAGINAL 050793-001 Nov 30, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Vintage Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 203343-001 May 29, 2015 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 065346-001 Mar 29, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aqua Pharms Llc VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 BX RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062747-001 Jun 3, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062819-001 Mar 15, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062908-001 Feb 1, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Loch CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062905-001 May 9, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CLINDAMYCIN PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Perrigo Pharma Intl CLINDESSE clindamycin phosphate CREAM;VAGINAL 050793-001 Nov 30, 2004 ➤ Sign Up ➤ Sign Up
Perrigo Pharma Intl CLINDESSE clindamycin phosphate CREAM;VAGINAL 050793-001 Nov 30, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for CLINDAMYCIN PHOSPHATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,749,488 Pharmaceutical foam ➤ Sign Up
6,517,847 Topical gel delivery system ➤ Sign Up
8,586,008 Pharmaceutical foam ➤ Sign Up
9,486,394 Pharmaceutical foam ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for CLINDAMYCIN PHOSPHATE

Supplementary Protection Certificates for CLINDAMYCIN PHOSPHATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992/01 Switzerland ➤ Sign Up PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
90049-3 Sweden ➤ Sign Up PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
401 Luxembourg ➤ Sign Up PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
4 Finland ➤ Sign Up
2013025 Lithuania ➤ Sign Up PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
13/044 Ireland ➤ Sign Up PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2013 00053 Denmark ➤ Sign Up PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
00617 Netherlands ➤ Sign Up PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Colorcon
Daiichi Sankyo
Johnson and Johnson
McKesson
Moodys
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot